Literature DB >> 11223201

Utilization of stress in the development of an equine model for equine protozoal myeloencephalitis.

W J Saville1, R W Stich, S M Reed, C J Njoku, M J Oglesbee, A Wunschmann, D L Grover, A L Larew-Naugle, J F Stanek, D E Granstrom, J P Dubey.   

Abstract

Neurologic disease in horses caused by Sarcocystis neurona is difficult to diagnose, treat, or prevent, due to the lack of knowledge about the pathogenesis of the disease. This in turn is confounded by the lack of a reliable equine model of equine protozoal myeloencephalitis (EPM). Epidemiologic studies have implicated stress as a risk factor for this disease, thus, the role of transport stress was evaluated for incorporation into an equine model for EPM. Sporocysts from feral opossums were bioassayed in interferon-gamma gene knockout (KO) mice to determine minimum number of viable S. neurona sporocysts in the inoculum. A minimum of 80,000 viable S. neurona sporocysts were fed to each of the nine horses. A total of 12 S. neurona antibody negative horses were divided into four groups (1-4). Three horses (group 1) were fed sporocysts on the day of arrival at the study site, three horses were fed sporocysts 14 days after acclimatization (group 2), three horses were given sporocysts and dexamethasone 14 days after acclimatization (group 3) and three horses were controls (group 4). All horses fed sporocysts in the study developed antibodies to S. neurona in serum and cerebrospinal fluid (CSF) and developed clinical signs of neurologic disease. The most severe clinical signs were in horses in group 1 subjected to transport stress. The least severe neurologic signs were in horses treated with dexamethasone (group 3). Clinical signs improved in four horses from two treatment groups by the time of euthanasia (group 1, day 44; group 3, day 47). Post-mortem examinations, and tissues that were collected for light microscopy, immunohistochemistry, tissue cultures, and bioassay in KO mice, revealed no direct evidence of S. neurona infection. However, there were lesions compatible with S. neurona infection in horses. The results of this investigation suggest that stress can play a role in the pathogenesis of EPM. There is also evidence to suggest that horses in nature may clear the organism routinely, which may explain the relatively high number of normal horses with CSF antibodies to S. neurona compared to the prevalence of EPM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223201     DOI: 10.1016/s0304-4017(00)00421-0

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  9 in total

1.  Equine protozoal myeloencephalitis caused by Neospora hughesi in an adult horse in Saskatchewan.

Authors:  Bruce K Wobeser; Dale L Godson; Daniel Rejmanek; Patricia Dowling
Journal:  Can Vet J       Date:  2009-08       Impact factor: 1.008

2.  Reduced levels of nitric oxide metabolites in cerebrospinal fluid are associated with equine protozoal myeloencephalitis.

Authors:  Chinedu J Njoku; William J A Saville; Stephen M Reed; Michael J Oglesbee; Päivi J Rajala-Schultz; Roger W Stich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 3.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

4.  Infection of immunodeficient horses with Sarcocystis neurona does not result in neurologic disease.

Authors:  Debra C Sellon; Donald P Knowles; Ellis C Greiner; Maureen T Long; Melissa T Hines; Tressa Hochstatter; Ahmed Tibary; John B Dame
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Evidence that antibodies against recombinant SnSAG1 of Sarcocystis neurona merozoites are involved in infection and immunity in equine protozoal myeloencephalitis.

Authors:  Siobhan Ellison; Sharon Witonsky
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

6.  Polyparasitism is associated with increased disease severity in Toxoplasma gondii-infected marine sentinel species.

Authors:  Amanda K Gibson; Stephen Raverty; Dyanna M Lambourn; Jessica Huggins; Spencer L Magargal; Michael E Grigg
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

7.  Effects of Experimental Sarcocystis neurona-Induced Infection on Immunity in an Equine Model.

Authors:  S Rochelle Lewis; Siobhan P Ellison; John J Dascanio; David S Lindsay; Robert M Gogal; Stephen R Werre; Naveen Surendran; Meghan E Breen; Bettina M Heid; Frank M Andrews; Virginia A Buechner-Maxwell; Sharon G Witonsky
Journal:  J Vet Med       Date:  2014-11-12

Review 8.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

9.  First molecular characterization of Sarcocystis neurona causing meningoencephalitis in a domestic cat in Brazil.

Authors:  Márcia Elisa Hammerschmitt; Luan Cleber Henker; Juliana Lichtler; Fernanda Vieira Amorim da Costa; Rodrigo Martins Soares; Horwald Alexander Bedoya Llano; Saulo Petinatti Pavarini
Journal:  Parasitol Res       Date:  2020-01-04       Impact factor: 2.289

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.